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RESEARCH ARTICLE
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Analysis of the genes retained in the minimized Mycoplasma JCVI-Syn3A
genome established that systems that repair or preempt metabolite damage are essential
to life. Several genes known to have such functions were identiﬁed and experimentally
validated, including 5-formyltetrahydrofolate cycloligase, coenzyme A (CoA) disulﬁde reductase, and certain hydrolases. Furthermore, we discovered that an enigmatic YqeK hydrolase domain fused to NadD has a novel proofreading function in NAD synthesis and
could double as a MutT-like sanitizing enzyme for the nucleotide pool. Finally, we combined metabolomics and cheminformatics approaches to extend the core metabolic map
of JCVI-Syn3A to include promiscuous enzymatic reactions and spontaneous side reactions. This extension revealed that several key metabolite damage control systems remain
to be identiﬁed in JCVI-Syn3A, such as that for methylglyoxal.

ABSTRACT

IMPORTANCE Metabolite damage and repair mechanisms are being increasingly recognized. We present here compelling genetic and biochemical evidence for the universal
importance of these mechanisms by demonstrating that stripping a genome down to
its barest essentials leaves metabolite damage control systems in place. Furthermore,
our metabolomic and cheminformatic results point to the existence of a network of
metabolite damage and damage control reactions that extends far beyond the corners
of it that have been characterized so far. In sum, there can be little room left to doubt
that metabolite damage and the systems that counter it are mainstream metabolic
processes that cannot be separated from life itself.
KEYWORDS comparative genomics, metabolite repair, metabolomics, minimal

genome, hydrolase

A

foundational goal of synthetic biology was to create a minimal living organism by
a bottom-up approach (1). This goal was reached in 2016 with the creation of
JCVI-Syn3.0 (2). This organism was built from the ruminant pathogen Mycoplasma
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FIG 1 5-FCL activity is encoded by JCVISYN3A_0400. (A) Enzymatic source and repair of 5-CHO-THF. (B)
Growth phenotype of a wild-type (WT) E. coli BW25113, a DygfA mutant, and a DygfA mutant expressing the
JCVISYN3A_0443 gene on M9 minimal medium (0.4% glucose) with 20 mM NH4Cl (plate 1) or 50 mM glycine
(plate 2) as sole nitrogen source. Plates were incubated for 3 days at 37°C.

mycoides subsp. capri serovar LC GM12 by DNA synthesis, recombination, and genome
transplantation techniques and included only genes required for survival or to support
a reasonable growth rate (428 protein-coding genes and 34 RNA genes) (2). The initial
JCVI-Syn3.0 strain was extremely fragile; a derivative with 18 more genes, JCVI-Syn3A,
was more stable and was the basis for a metabolic model (3). Surprisingly, when JCVISyn3.0 was published in 2016, ;30% of its genes could not be assigned a speciﬁc function. The initial annotation has since been improved by manual curation (4), metabolic
modeling (3), and further in silico analyses (5), but ;85 proteins with unknown or
vaguely deﬁned functions remain (see Supplemental data A1 at ﬁgshare [https://doi
.org/10.6084/m9.ﬁgshare.20020574]). These unknowns cannot all be missing parts of
synthesis/breakdown pathways as the metabolic reconstruction identiﬁed only four
metabolic and eight transport reactions as missing (3).
A crucial area of metabolism usually left out of metabolic models is metabolite
damage and repair. Enzymes make mistakes, and metabolites undergo spontaneous
chemical reactions (6, 7). These damage reactions are ever present and, when the
resulting products are toxic, can reduce ﬁtness (6, 8). It has been shown recently that
many enzymes of formerly unknown function repair or preempt metabolite damage
(9–11), that mutations in metabolite repair enzymes cause human diseases (12–14),
and that pathway engineering can fail unless appropriate repair enzymes are installed
(15). The emerging recognition of the nature and extent of metabolite damage and
repair raised the question of the importance of metabolite repair for a minimal genome like JCVI-Syn3/3A. By combining expert manual curation, comparative genomics,
metabolomics, metabolic modeling, cheminformatics, and experimental validation, we
identiﬁed a set of chemical damage reactions likely to occur in JCVI-Syn3 and some of
the damage repair and preemption activities that this minimal genome encodes.
RESULTS AND DISCUSSION
Identiﬁcation and validation of homologs of known metabolite repair enzymes.
We ﬁrst manually screened the predicted proteome of JCVI-Syn3A for homologs of known
metabolite repair enzymes (6, 15, 16) (see Supplemental data S1 and Appendix at ﬁgshare
[https://doi.org/10.6084/m9.ﬁgshare.20020574]). Several were found, as follows.
(i) 5-FCL. 5-Formyltetrahydrofolate (5-CHO-THF) is a by-product of serine hydroxymethyltransferase (SHMT) (17) (Fig. 1A) that inhibits folate-dependent enzymes and
must therefore be recycled or destroyed (18). Of various enzymes known to recycle 5CHO-THF (19), the most widespread is 5-formyltetrahydrofolate cycloligase (5-FCL)
(encoded by fau/ygfA [16] in Escherichia coli). The JCVI-Syn3A genome encodes a 5-FCL
July/August 2022 Volume 13 Issue 4
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FIG 2 Predicted and validated redox buffering systems in JCVI-Syn3. (A) Candidates for H2O2 detoxiﬁcation systems of JCVI-Syn3;
those experimentally validated are shown by solid arrows, only the numbers of the locus tags are given, P is for protein, and R is
for small molecule. The predicted source of reductant is NADPH. (B) CoADR Michaelis-Menten saturation curve for the
determination of the Km and kcat for CoAD consumption. (C) CoADR is speciﬁc toward oxidized CoA with no activity toward other
tested disulﬁdes.

homolog (JCVISYN3A_0443); this gene was conﬁrmed to encode an active 5-FCL by a
complementation assay. Speciﬁcally, an E. coli K-12 DygfA strain does not grow on M9
minimal medium with 0.2% glucose as carbon source and 20 mM glycine as sole nitrogen source (19) (Fig. 1B). Expression of JCVISYN3A_0443 from a plasmid complemented this growth phenotype (Fig. 1B). Note that the essentiality of JCVISYN3A_0443
might be due both to its repair function and to a role as a source of 5,10-methenyltetrahydrofolate-polyglutamate (3).
(ii) Thiol reductases. Like all aerobes, JCVI-Syn3A encounters oxidative stress that
can damage macromolecules. Maintaining protein and small-molecule thiol groups in
their reduced state is critical for cellular redox homeostasis (20). Thioredoxin/thioredoxin
reductase is the dominant protein thiol oxidoreductase system in many organisms, using
reducing equivalents ultimately derived from NAPDH (21, 22). The JCVI-Syn3A genome
encodes homologs of the thioredoxin system proteins (TrxB/JCVISYN3A_0819 and TrxA/
JCVISYN3A_0065) that are most likely involved in reducing protein disulﬁde bonds and
have been partially characterized in other Mycoplasma species (Fig. 2A) (23, 24). Both
genes are essential (see Supplemental data A1 at ﬁgshare [https://doi.org/10.6084/m9
.ﬁgshare.20020574]), supporting key roles for TrxA and TrxB in disulﬁde bond reduction.
Note, however, that thioredoxin is also the electron donor for ribonucleotide reductase,
so that JCVISYN3A_0819 and JCVISYN3A_0065 may be essential for this reason (23, 25).
JCVISYN3A_0887 is a homolog of coenzyme A (CoA) disulﬁde reductase (CoADR),
which may have a major redox role in certain bacteria (26). Because CoA is required for
several reactions in the JCVI-Syn3A metabolic model and is predicted to be imported
from the medium, CoADR could maintain the CoA pool in the reduced state. Testing
the CoADR activity of JCVISYN3A_0887 showed that it is an active CoADR that operates
well at physiological pH (pH 7.5) (27) and has reasonable Km (0.17 mM) and kcat (2.8 s21)
values (Fig. 2B). It lacks detectable activity against oxidized glutathione or pantethine
(Fig. 2C). While we cannot exclude the possibility that reduced glutathione is imported
from the medium and oxidized glutathione is exported, a CoA-based system is a more
parsimonious solution to the redox balance problem.
July/August 2022 Volume 13 Issue 4
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TABLE 1 Members of the HAD family of unknown function encoded by JCVI-Syn3

Gene
JCVISYN3A_0066

JCVISYN3A_0077
JCVISYN3A_0710

JCVISYN3A_0728

JCVISYN3A_0907

Family
Cof subfamily of IIB
subfamily of HAD
superfamily
Cof-like hydrolase, HAD
superfamily
Cof subfamily of IIB
subfamily of HAD
superfamily
HAD superfamily
hydrolase subfamily
IIB, protein
Cof-like hydrolase, HAD
superfamily

M. ﬂorum ortholog,
locus tag and
essentialityb
Mﬂ169 (NE)

Essential
No

Best 3 substrates with
activity in vitroa
pNPP, FMN, CoA

No

Fru-1P, Ery-4P

Between tsaD and aspS

Mﬂ614 (E)

Yes

Could not clone

Mﬂ513 (E)

No

GMP; XMP; 2deoxyglucose-6P

Between tRNA genes
and predicted
phosphonate
transporter genes
Between glycolysis
genes

No

N-Acetyl-D-glucosamine6P; fructose-1P;
N-acetyl-D-glucosamine1P

Physical clustering
Between 5S rRNA gene
and thioredoxin

Between YidC and
choline kinase-like

Mﬂ503 (E)

Mﬂ680 (NE)

are in Table S1 at ﬁgshare (https://doi.org/10.6084/m9.ﬁgshare.20020574).
essential, and NE, nonessential in M. ﬂorum.

aAbbreviations
bE,

Functional analysis of HAD proteins identiﬁes a nucleotide phosphatase with
possible dual roles. Our second strategy to identify metabolite repair enzymes was based
on the demonstration that hydrolases of previously uncertain or unknown function were
subsequently shown to participate in metabolite repair (9). Five genes encoding standalone
members of the HAD (haloacid dehalogenase) hydrolase family (28) were identiﬁed in the
JCVI-Syn3A genome (see Supplemental data S1 at ﬁgshare [https://doi.org/10.6084/m9
.ﬁgshare.20020574]) and are conserved in the closely related Mesoplasma ﬂorum L1 genome (29) (Table 1). Such HAD hydrolases often participate in metabolite repair or homeostasis, as many damaged or toxic intermediates are phosphorylated (e.g., phosphosugars),
and their recycling or removal requires a phosphatase (9, 30).
Comparative genomic analysis of the standalone HADs did not point to clear functional hypotheses, except for JCVISYN3A_0728, whose location in a predicted operon
with triose-phosphate isomerase and phosphoglycerate mutase suggested a role in
sugar phosphate metabolism (Table 1). Possible functions for the HAD proteins included
(i) repair of substrates to be identiﬁed, (ii) missing phosphatases involved in primary metabolism identiﬁed by the metabolic model such as sedoheptulose 1,7-bisphosphate
phosphatase or phosphatidate phosphatase, and (iii) nucleotide phosphatases involved
in deoxynucleoside triphosphate (dNTP) pool maintenance. To discriminate among these
hypotheses, we combined biochemistry, genetics, and metabolomics.
The four HAD proteins that we were able to express in E. coli (JCVISYN3A_0066,
JCVISYN3A_0077, JCVISYN3A_0728, and JCVISYN3A_0907) were tested for activity against
a panel of 94 phosphatase substrates (see Table A1 at ﬁgshare [https://doi.org/10.6084/
m9.ﬁgshare.20020574]) (31). The four proteins had detectable activity against the model
phosphatase substrate p-nitrophenyl phosphate (pNPP) and different physiological
substrates (see Fig. A1 at ﬁgshare [https://doi.org/10.6084/m9.ﬁgshare.20020574]). The
JCVISYN3A_0728 enzyme hydrolyzed a wide range of nucleoside and sugar phosphates,
the JCVISYN3A_0907 and JCVISYN3A_0077 enzymes hydrolyzed narrower ranges of sugar
phosphates, and the JCVISYN3A_0066 enzyme hydrolyzed ﬂavin mononucleotide (FMN)
and CoA. That sugar phosphates are good substrates of JCVISYN3A_0728 is consistent
with its genomically predicted role in sugar phosphate metabolism, but no speciﬁc function or substrate could be assigned. Note, however, that the 94-substrate panel did not
include damaged sugar phosphates.
We attempted to delete HAD-encoding genes in JCVI-Syn3A, expecting this to be
possible because transposon bombardment of the JCVI-Syn3A genome indicated that
all ﬁve HADs were quasiessential (i.e., required for fast growth but not for viability) (3)
July/August 2022 Volume 13 Issue 4
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FIG 3 Heatmap including 15 metabolites from JCVI-Syn3A mutant metabolomic analysis with highest VIP scores.
Samples and genotypes are represented in columns. High-intensity measurements compared to average intensity are
red/yellow, and low-intensity measurements are represented by green/blue.

(see also Supplemental data S1 at ﬁgshare [https://doi.org/10.6084/m9.ﬁgshare.20020574]).
Deletants were readily obtained for genes JCVISYN3A_0066, JCVISYN3A_0077, JCVISYN3A_
0728, and JCVISYN3A_0907 (see Supplemental data S2 at ﬁgshare [https://doi.org/10
.6084/m9.ﬁgshare.20020574]). Attempts to delete JCVISYN3A_0710 using two different
methods were unsuccessful (see Supplemental data S2 at the ﬁgshare URL above).
Deletion of this gene could have resulted in an extremely slow-growing strain that was
unrecoverable under the conditions used, Alternatively, JCVISVN3A_0710 could be essential, the transposon insertions in the gene being artifacts. That the same gene is also essential in M. ﬂorum (Table 1) favors the latter hypothesis.
We observed no major differences in growth rates between JCVI-Syn3A and any
HAD mutant (see Fig. A2 at ﬁgshare [https://doi.org/10.6084/m9.ﬁgshare.20020574]).
To conduct a metabolomics analysis, the four mutants and the JCVI-Syn3A parent were
grown in SP4-KO medium (deﬁned in Materials and Methods) and harvested at the
same point of log-phase growth. (see the Appendix and Tables A2 and A3, all at ﬁgshare [https://doi.org/10.6084/m9.ﬁgshare.20020574]). A total of 4,152 features were
detected in the samples using hydrophilic interaction liquid chromatography (HILIC)
and mass spectrometry (see Supplemental data S3 at ﬁgshare [https://doi.org/10.6084/
m9.ﬁgshare.20020574]), of which 522 were annotated as known metabolites.
Partial least-squares discriminant analysis was used to ﬁnd the variable importance in projection (VIP) scores of each annotated metabolite. The 15 metabolites
with the highest VIP scores (Fig. 3; see also Fig. A3 at ﬁgshare [https://doi.org/10
.6084/m9.ﬁgshare.20020574]) showed little contamination from media, as determined by analysis of unused media along with mutant samples. Most of these metabolites were below the limit of detection in unused media, and most of the rest were
present at a .30-fold-lower abundance in media than in samples, suggesting little or
no contamination from residual media (see Supplemental data S3 at ﬁgshare [https://
doi.org/10.6084/m9.ﬁgshare.20020574]). Two metabolites (cytidine and thiamine)
were found at similar abundances in media and samples, suggesting these medium
contaminations.
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Among the 15 metabolites with high VIP scores, the JCVISYN3A_0728 knockout
showed signiﬁcantly higher abundances of glycerophosphate, oleoyl lysophosphatidic
acid, and palmitoylglycerol than other genotypes (Fig. 3; see also Fig. A3 at ﬁgshare
[https://doi.org/10.6084/m9.ﬁgshare.20020574]). We were not able to determine which
form of glycerophosphate was increased, although the 3-phosphate is a priori more
likely, being found in the metabolic model as a cardiolipin metabolism intermediate that
is synthesized via phosphorylation of imported glycerol by GlpK (JCVISYN3A_0218). To
further analyze the knockout metabolomics data further, all four HAD hydrolase knockout phenotypes were separately compared to wild-type JCVI-Syn3A (see Supplemental
data S3 at ﬁgshare [https://doi.org/10.6084/m9.ﬁgshare.20020574]). The conclusions are
summarized below and further discussed in the Appendix at ﬁgshare (https://doi.org/10
.6084/m9.ﬁgshare.20020574).
The metabolomics data suggest that JCVISYN3A_0066 is the major deoxyribonucleoside monophosphatase (dNMPase) with activity against the deoxymononucleotides dAMP,
dGMP, dUMP, dCMP, dTMP, and dIMP and also the ribomononucleotide IMP. Furthermore,
as further discussed in the Appendix at ﬁgshare (https://doi.org/10.6084/m9.ﬁgshare
.20020574), the data also suggest the residual presence of pyrimidine nucleoside phosphorylase (PyNP) activity in JCVI-Syn3A after the known MMSYN1_0734 has been removed.
The lack of observed nucleotidase activity for JCVISYN3A_0066 in the in vitro substrate
screen could be due to the absence of relevant effectors. In contrast, it seems that
JCVISYN3A_0077 is also a dUMP-speciﬁc speciﬁc dNMPase that plays a minor role in vivo
compared to JCVISYN3A_0066. The metabolomics data also suggest that JCVISYN3A_0728
is a glycerol 3-phosphate phosphatase. The other activities detected in vitro, if relevant in
vivo, might not be apparent in the metabolomics data if these substrates do not accumulate in cells. No functional role could be proposed for JCVISYN3A_0907.
Comparative genomics uncovers a possible metabolite repair diphosphatase.
The YqeK histidine -aspartate (HD)-domain phosphohydrolase is fused to nicotinic acid
mononucleotide adenylyltransferase (NadD) in most mycoplasmas and strongly physically
clustered with NadD in many other Gram-positive organisms (32) (Fig. 4; see also Fig. A4A
at ﬁgshare [https://doi.org/10.6084/m9.ﬁgshare.20020574]). These genomic associations
led us to propose that YqeK repairs mistakes made by NadD. The canonical activity of
NadD is to adenylate nicotinate-ribonucleotide (NaMN) using ATP as a donor of the AMP
moiety (Fig. 4A). However, use of another NTP or the deoxy-form of ATP would create an
erroneous product requiring disposal, most likely by hydrolysis. We therefore expressed
JCVISYN3A_0380 and its His230Ala variant in E. coli (see Fig. A4B at ﬁgshare [https://doi
.org/10.6084/m9.ﬁgshare.20020574]). (The His230Ala mutation is predicted to abolish
phosphatase activity that would interfere with NadD activity measurement.) Bacillus subtilis NadD was used as a benchmark. The JCVISYN3A_0380 His230Ala protein and B. subtilis
NadD were tested for in vitro activity with various nucleoside triphosphates as the substrates. The adenylating activity of the JCVISYN3A_0380 His230Ala mutant was quite nonspeciﬁc and actually greater against dATP, CTP, or UTP than against the physiological substrate, ATP, whereas B. subtilis NadD strongly preferred ATP (Fig. 5A). JCVI-Syn3 NadD can
therefore readily form deoxyadenosine, deoxycytidine, or deoxyuridine analogs of the
NAD precursor nicotinate adenine dinucleotide (NaAD), which can presumably be converted to inhibitory analogs of NAD and NADP.
We then tested the JCVI-Syn3 YqeK domain for diphosphatase activity using the
NaAD analogs that could be produced by JCVI-Syn3A NadD. The YqeK domain had activity toward the cytosine (NaCD) and uracil (NaUD) analogs of NaAD that was at least
as high as that against NaAD itself (Fig. 5B), which agrees with the preference of the
NadD domain to form these analogs.
We also observed that the YqeK domain had high activity against 8-oxo-GTP,
although judging from relative activities with 0.05 mM and 0.5 mM substrate, the Km is
likely higher than that for the other substrates tested (Fig. 5B). Consistent with this
ﬁnding, we showed that the genes encoding the JCVI-Syn3A NadD-YqeK fusion can
partially complement the E. coli mutT high-mutation-rate phenotype (measured as Rifr
July/August 2022 Volume 13 Issue 4
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FIG 4 Predicted hydrolase of unknown function is clustered or fused to NadD in many Firmicutes. (A) Predicted NADP1 synthesis
pathway in JCVI-Syn3. (B) Physical clustering and fusions of nadD and ykeK homologs in several Gram-positive bacteria. The RefSeq
identiﬁers for the yqeK genes used in descending order are CAE77070, NP_390441.1, by AAW38265.1, AAO82560.1, and AAV61221.1.

ratios) (Fig. 5C). The partial complementation was also observed when expressing the
YqeK domain alone but not the NadD domain alone. Finally, it was recently shown that
YqeKs of Gram-positive bacteria belong to a novel diadenosine tetraphosphate (Ap4A)
hydrolase family (33). Taken together, these observations suggest that YqeK is a versatile diphosphatase with several functional roles.
Indeed, the available transposon insertion data (3) (see also Supplemental data S1
at ﬁgshare [https://doi.org/10.6084/m9.ﬁgshare.20020574]) suggested that the NadD
domain is essential and the YqeK domain is quasiessential because a few hits in the
YqeK region of the gene were detected in the ﬁrst Transposon (Tn) round and disappeared after the fourth round. We could not isolate a JCVISYN3A_0380 deletant despite several attempts. We were, however, able to construct a strain carrying the
His230Ala mutation that inactivates YqeK diphosphatase activity (see Supplemental
data S2 at ﬁgshare [https://doi.org/10.6084/m9.ﬁgshare.20020574]), and this strain
showed no growth defect or obvious metabolite imbalance (see Fig. A2 at ﬁgshare
[https://doi.org/10.6084/m9.ﬁgshare.20020574]).
Metabolomics-driven exploration of damage and repair chemistry in JCVISyn3. Thus far, all of our damage and repair cases began with analysis of genes in the
JCVI-Syn3A genome and uncovered clear instances of metabolite damage and repair.
But are these examples isolated exceptions, or the tip of an iceberg of uncharacterized
metabolic chemistry? To address this question, we adopted a systematic exploratory
approach based on the metabolomics data for JCVI-Syn3A cells (see Table S3 at ﬁgshare [https://doi.org/10.6084/m9.ﬁgshare.20020574]). Because this approach begins with
the observed chemical results of potential metabolite damage and is not limited by our
current knowledge of gene function, it will certainly ﬁnd damage mechanisms that our
July/August 2022 Volume 13 Issue 4
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FIG 5 Biochemical analysis of the NadD and YqeK activities. (A) Relative reaction rates of Bacillus subtilis and JCVI-Syn3.0 NadD enzymes with NaMN and
various nucleotides, calculated as percentage of the canonical reaction with ATP for each NadD enzyme. Enzymes were incubated with 2 mM NTP, 0.5 mM
NaMN, 4 mM MgCl2, and 5 U/mL yeast inorganic pyrophosphatase for 5 min at 37°C. H230A has the conserved H in the active site of the YqeK domain
mutated to ablate the HD activity and cleavage of nucleotides. (B) Activity of the expressed JCVI-Syn3.0 YqeK domain with different substrates. YqeK
(0.2 m g) was incubated with 0.5 or 0.05 mM concentrations of the substrates, 1 mg/mL bovine serum albumin, and 2.0 mM MgCl2 for 20 min at 37°C. Black
bars are data for 0.5 mM substrates, and white bars are data for 0.05 mM substrates. (C) Mutation ratio on LB-rifampicin for DmutT strain with empty
vector (pBAD24), DmutT strain with E. coli mutT in trans, and DmutT strain with either the nadD-yqeK fusion gene JCVISYN3A_0380 or the nadD or yqeK
domain alone. *** indicates a P value of ,0.001 with experiments performed with four biological replicates and four technical replicates.

gene-ﬁrst approach will miss. Still, this approach will also miss any damage mechanisms
that fail to be observed through metabolomics, either due to volatility of end products or
due to extremely effective damage mitigation systems.
We focused speciﬁcally on a set of 480 metabolites (see Table S4E at ﬁgshare
[https://doi.org/10.6084/m9.ﬁgshare.20020574]) that satisﬁed two criteria: (i) the mass
spectral signal was conﬁdently identiﬁed with a deﬁned molecular structure, and (ii)
the metabolite was at least as abundant in the JCVI-Syn3A cells as in the growth medium. We compared the 480 identiﬁed peaks to the 304 metabolites in the JCVI-Syn3A
model and the 33,978 compounds in the ModelSEED database (34), resulting in 57
matches to the model and 217 (45%) matches to the database (see Table S4E at the ﬁgshare URL above). The comparison to the JCVI-Syn3A model reveals two types of discrepancy: (i) 247 metabolites in our model do not appear in our metabolomics data,
which is to be expected as many metabolites are too low in concentration or too volatile to be detected in metabolomics, and (ii) 423 metabolites that were observed and
do not appear in our model, which is more problematic as this implies that there is signiﬁcant chemistry taking place in this system that our present model cannot explain.
The ModelSEED database lookup reveals further discrepancies: (i) 263 observed metabolites do not appear in biochemistry databases, indicating that there is no known biochemical route to any of these compounds that are observed to arise in a biological
system, and (ii) 160 observed metabolites (217 to 57) do have known biochemical biosynthesis mechanisms, but these mechanisms do not appear in our current JCVI-Syn3
model (3). To predict potential chemical routes to as many of the observed metabolites as
possible without limiting our search to known chemistry or straying too far from known
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FIG 6 Number of predicted potential metabolites arising from promiscuous enzymatic reactions and
spontaneous/damage chemistry operating on known compounds in JCVI-Syn3 metabolism. Total predicted
metabolites are shown, as well as the number of metabolites matching observed peaks (blue line) or
ModelSEED compounds (green line). The x axis indicates the number of reaction steps explored outward from
the known JCVI-Syn3 metabolism, while the y axis shows the number of new metabolites predicted with each
new reaction step.

JCVI-Syn3A metabolism, we used the PickAxe tool (35). This tool applies generalized reaction rules based on known spontaneous (8) and enzymatic (36, 37) chemical mechanisms
to predict potential novel reactions that a given set of metabolites (here, all JCVI-Syn3A
metabolites) could undergo. We started with the 304 metabolites present in the JCVISyn3A model and applied PickAxe for multiple iterations to allow generation of multistep
pathways (see Materials and Methods). We used both spontaneous and enzymatic reaction rules in the PickAxe expansion, enabling prediction of pathways with a mixture of
both (as occurs in many damage and repair pathways). The initial PickAxe iterations uncovered an increasing number of compounds generated that matched the observed metabolites, but these hits tapered off after six iterations to just one new compound produced
that matched an observed metabolite (blue line in Fig. 6). The number of compounds predicted by PickAxe that matched known biochemistry in the ModelSEED database (green
line in Fig. 6) followed a similar trend. We halted the PickAxe expansion at this stage, given
its diminishing returns. The ﬁnal chemical network generated by PickAxe included 33,934
compounds and 61,939 reactions and matched a total of 182 distinct metabolites (including the original 57 matching the JCVI-Syn3 model) and 1,090 ModelSEED compounds (see
Supplemental data S4C and D at ﬁgshare [https://doi.org/10.6084/m9.ﬁgshare.20020574]).
Next, we used a new ﬂux balance analysis (FBA) formulation, metabo-FBA, to select
a minimal subset of these reactions that connect the functioning JCVI-Syn3A model to
as many observed metabolites as possible using mass- and energy-balanced pathways
(see Materials and Methods). Because our study is of a minimal genome with relatively
few enzymes and speciﬁcally focuses on metabolite damage, we favored solutions that
involved as many reactions generated by spontaneous reaction rules as possible. This
approach produced a predicted ﬂux proﬁle that simultaneously pushed ﬂux through
reactions involving compounds that matched 182 observed metabolites (see solution
depicted in Fig. 7 and data in Supplemental data S4A and E at ﬁgshare [https://doi.org/
10.6084/m9.ﬁgshare.20020574]). This solution included 145 (58%) of the 252 reactions
in the JCVI-Syn3 model (purple reactions in Fig. 7), 129 additional ModelSEED reactions
(primarily predicted enzymatic reactions; green reactions in Fig. 7), 84 novel enzymatic
reactions (blue reactions in Fig. 7), and 74 novel spontaneous reactions (red reactions
in Fig. 7) (see data in Supplemental data S4A at the ﬁgshare URL above). The ﬁxed
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FIG 7 Map of predicted extensions to the JCVI-Syn3 model to push ﬂux through as many observed peaks as possible. Reactions and metabolites are color
coded as shown in the inset. Model reactions with no ﬂux are black, and those with ﬂux are magenta. Predicted and active reactions that are in the
database are green, those that are novel and spontaneous are red, and those that are novel enzymatic ones are blue. All active predicted spontaneous
reactions and nearly all active model reactions are shown on the map; some ModelSEED and predicted enzymatic reactions are excluded. The color code
for metabolites is as follows: those absent in the mass spectrometry analysis are white, observed metabolites that are also in the model are yellow, those
in the database are ocher, and those that are novel in themselves or in the way they are produced are brown. Most enzymatic reactions are identiﬁed by
their EC numbers. Some reactants’ names have been omitted since they do not give relevant information. Common abbreviations have been used for the
name labels. The map has been divided by panels shown on the ﬁgure’s background. These panels are labeled according to the major pathway they
display. The complete metabolic map in interactive format (Escher map) is given in Supplemental data S5 at ﬁgshare (https://doi.org/10.6084/m9.ﬁgshare
.20020574).

image of our ﬂux solution depicted in Fig. 7 is of limited value for permitting a detailed
exploration of the ﬂuxes, so we are also including all data ﬁles and instructions needed
to replicate this view in a fully functioning dynamic Escher map (see Supplemental
data S5 at ﬁgshare [https://doi.org/10.6084/m9.ﬁgshare.20020574]). Also, the fully
expanded version of the JCVI-Syn3A model used to generate this ﬂux solution is provided in SBML and JSON format in Supplemental data S5 at the ﬁgshare URL above.
This ﬂux solution is only one of many possible solutions that can explain the
observed metabolomics data. While it is unlikely that this solution is completely correct, the true solution must make use of similar chemistry, start with the same initial
high-conﬁdence JCVI-Syn3A compounds, and produce the same observed metabolic
intermediates, meaning the true solution cannot differ very substantially from our
selected one.
The map broadly (Fig. 7) shows clear hot spots of chemical expansion (adenine, cytosine, sugars, pyruvate, amino acids, central carbon trunk reactions, and CoA) and
regions with little or none (deoxynucleotides, guanine, thymidine, THF, riboﬂavin,
NAD). This is probably explained by the intrinsic reactivities and the concentrations of
the associated compounds. Many of the hot spot compounds are high-concentration
metabolic starting points (e.g., sugars), end points (e.g., amino acids), or high-ﬂux intermediates (e.g., pyruvate). Their high concentrations make it more likely that these compounds will react chemically and that metabolomics will detect the resulting products.
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The many ModelSEED reactions and predicted novel enzymatic reactions proposed
by this approach represent previously unannotated but potential promiscuous side
activities of existing annotated gene products in JCVI-Syn3A. The metabolomic evidence for the presence of the products of these reactions points strongly to the presence of the reactions themselves. The cluster of ModelSEED reactions expanding from
the glucose-6-phosphate (g6p) node of the JCVI-Syn3A model is a good example
(Fig. 7). These reactions are phosphorylations and hydrolyses that interconvert many
diverse sugars and polysaccharides, all of which are supported by our metabolomics
data. As the model contains reactions for glucose only as a representative sugar, it
probably understates the extent of such reactions.
Also of note is how many of the pathways predicted in JCVI-Syn3A by our metaboFBA method involve a mixture of database reactions, predicted spontaneous reactions,
and novel enzymatic reactions (30/50 total pathways). Any analysis based on just one
or two of these three reaction sources would explain a far smaller number of observed
metabolites due to gaps and dead ends in the predicted pathways. Thus, using all
three reaction data sources provides a much fuller understanding of metabolism.
Another notable point is that much of the new predicted chemistry surrounds
amino acids. Many of the observed metabolomics peaks correspond to amino acid
derivatives such as dipeptides and acetylated amino acids (Fig. 7). The dipeptides serve
primarily as nutrients for JCVI-Syn3, which contains the peptidases needed to degrade
these compounds (a large number of the ModelSEED reactions added by our metaboFBA approach relate to dipeptide transport and degradation). The acetylated amino
acids are different in that only 7 out of 10 of these compounds were found in biochemistry databases, and the databases lacked spontaneous acetylation reactions to produce these compounds. Yet, metabolomics evidence supported the presence of all 10
in the JCVI-Syn3A strain. The metabo-FBA approach added 10 predicted spontaneous
acetylation reactions, using acetyl-phosphate as a donor, based on PickAxe predictions.
This demonstrates how readily acetylation occurs in these systems, either by spontaneous action or by promiscuous enzyme activity, and it highlights the particular vulnerability of amino acids to this acetylation.
These results also support previous hypotheses about the main metabolic network
of JCVI-Syn3A (3) with regard to acetyl phosphate and the enzymes producing/consuming it. The in vivo essentiality of phosphate acetyltransferase (JCVISYN3_0229) and
acetate kinase (JCVISYN3_0230) was previously puzzling, given that the upstream
genes in the pathway, the subunits of pyruvate dehydrogenase (JCVISYN3_0227/8),
were found to be nonessential in vivo. It had been hypothesized that the two former
enzymes were essential because buildups of acetyl-CoA or acetyl phosphate needed to
be prevented, both being known protein acetylation agents (38). The extensive and
diverse acetylation damage we found evidenced in our metabolomics data would
seem to further support this hypothesis.
Relatedly, our results support a role for acetyl phosphate in the acetylation of proteins as well as free amino acids because some of the identiﬁed amino acids had side
chain acetylations. The results also support the hypothesized essential role of acetate
kinase as a means of preventing acetyl phosphate accumulation.
These analyses also expose insights into the relative importance of our various proposed mechanisms for spontaneous chemistry, based on which mechanisms are most
likely to give rise to metabolic products found in our metabolomics data (see larger
discussion in the Appendix and Fig. A5 at ﬁgshare [https://doi.org/10.6084/m9.ﬁgshare
.20020574]). Of course, not all chemically impactful metabolites are readily observed in
metabolomics data due to instability or volatility. Methylglyoxal is a good example of
an important metabolite that arises from and participates in spontaneous damage
reactions but could not be observed (Fig. 7). While methylglyoxal was not among the
observed metabolites due to small size and volatility, metabo-FBA added reactions
involving this compound because it leads to numerous downstream potential damage
and repair reactions. A more detailed discussion of methylglyoxal follows.
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FIG 8 Characterization of JCVISYN3A_0400. (A) Growth of wild-type, DyajL, and DyajL DhchA strains; DyajL DhchA strain with hchA in trans; and DyajL
DhchA strain with JCVISYN3A_0400 in trans. pUC19 was used as an empty vector. Each strain was tested in 5 replicates. Plates were incubated 2 days at
37°C in LB with agitation in a Bioscreen C device. OD, optical density. (B) Methylglyoxalase (MG) activity of JCVISYN3A_0400 compared to human DJ-1 (DJ1)
and E. coli YajL. Conversion of methylglyoxal to L-lactate was measured in a coupled assay with L-lactate oxidase and Amplex red. Data were measured in
triplicate with error bars shown (sometimes smaller than the symbol) and ﬁtted using the Michaelis-Menten model. JCVISYN3A_0400 is a weak
methylglyoxalase.

Possible ways for JCVI-Syn3A to cope with methylglyoxal stress. Methylglyoxal is
necessarily formed from the triose phosphates in JCVI-Syn3A central metabolism (39), but
the classical glyoxalase system comprising the glutathione-dependent GloA and GloB
enzymes (40) is absent. Likewise, the JCVI-Syn3A genome does not encode enzymes with
minor methylglyoxal-detoxifying activities, such as aldose reductases and ketoaldehyde reductases (41–43). The only candidate gene for an enzyme that we identiﬁed as potentially
able to counter methylglyoxal-induced damage is JCVISYN3A_0400, which encodes a
homolog of DJ-1. The DJ-1 superfamily has several functionally distinct clades, of which
four are found in E. coli (encoded by hchA, yajL, yhbO, and elbB). Phylogenetic analysis places JCVISYN3A_0400 in the YajL/DJ-1 clade (see Fig. A6 at ﬁgshare [https://doi.org/10
.6084/m9.ﬁgshare.20020574]).
The members of the DJ-1 superfamily that have been functionally characterized
participate in stress response and detoxiﬁcation (44). Some are thought to be deglycases (45), glyoxalases (46), or aldehyde-adduct hydrolases (47). Previous studies
showed variability in the phenotypes reported for the E. coli hchA, yajL, and yhbO deletion mutants as the sensitivity of the yajL mutant reported by the Richarme group (48)
was not reproduced in independent studies (46). We also failed to reproduce the
reported glyoxal or methylglyoxal sensitivities of the single-deletion yajL mutant but
did observe a defect both in its growth rate and in the yield of the DyajL/DhchA E. coli
K-12 BW25113 strain (Fig. 8A; see also Fig. S7A at ﬁgshare [https://doi.org/10.6084/m9
.ﬁgshare.20020574]). Expression of the E. coli yajL or JCVISYN3A_0400 gene in trans
complemented this growth phenotype (Fig. 8A; see also Fig. A7A at ﬁgshare [https://
doi.org/10.6084/m9.ﬁgshare.20020574]), suggesting that JCVISYN3A_0400 is indeed in
the same DJ-1 subgroup as YajL.
To test the hypothesis that JCVISYN3A_0400 participates in methylglyoxal detoxiﬁcation, we measured the glyoxalase activity of the recombinant protein. JCVISYN3A_0400
possess a low but measurable methylglyoxalase activity (kcat = 0.025 6 0.002 s21, Km =
1.23 6 0.30 mM), lower than that obtained for the positive-control protein human DJ-1
(kcat = 0.126 6 0.004 s21, Km = 0.34 6 0.04 mM) but higher than that for E. coli YajL (kcat =
0.004 6 0.0001 s21, Km = 0.095 6 0.018 mM) (Fig. 8B). The low kcat for YajL is consistent
with a prior report that did not detect glyoxalase activity using methylglyoxal as a substrate (46). The ;20 M21 s21 kcat/Km value for JCVISYN3A_0400 is 5 to 6 orders of magnitude lower than that of glyoxalase I, the canonical glutathione-dependent glyoxalase (49).
Even compared to other DJ-1 superfamily glyoxalases, JCVISYN3A_0400 is a poor enzyme.
The lactate oxidase-coupled assay used here is speciﬁc to L-lactate, which should detect all
the lactate produced by JCVISYN3A_0400, as a prior study indicated that DJ-1 clade
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enzymes produce only the L enantiomer (50), although we did not test the enantiopurity
of the lactate produced by JCVISYN3A_0400 in this study.
Because DJ-1 superfamily members have been reported to be generalist deglycases
(51), we tested the deglycase activity of JCVISYN3A_0400 against the methylglyoxalCoA hemithioacetal (see Fig. A7B at ﬁgshare [https://doi.org/10.6084/m9.ﬁgshare
.20020574]). CoA was used as the thiol because the absence of glutathione biosynthetic enzymes in JCVI-Syn3A suggests that CoA is its main small-molecule thiol (see
above). JCVISYN3A_0400 had no detectable deglycase activity against methylglyoxalCoA hemithioacetal (see Fig. A7B at the ﬁgshare URL above), while human DJ-1 had a
low activity (kcat = 0.0068 6 0.0007 s21, Km = 0.144 6 0.064 mM) against the same substrate (52). JCVISYN3A_0400 therefore seems unlikely to efﬁciently detoxify methylglyoxal via either glyoxalase or deglycase pathways. It is possible that JCVISYN3A_0400
and other DJ-1-type glutathione-independent methylglyoxalases have some unidentiﬁed positive effector in vivo that enhances their activity, and the glyoxalase activity of
human DJ-1 is highly sensitive to buffer conditions (53). In summary, while results suggest that JCVISYN3A_0400 and YajL are isofunctional, they do not appear to make a
large contribution to methylglyoxal detoxiﬁcation.
The recent observation that human DJ-1, E. coli YajL, and Schizosaccharomyces pombe
DJ-1 can reduce the levels of modiﬁcations derived from 1,3-bisphosphoglycerate suggests
an alternative hypothesis for the function of JCVISYN3A_0400 and other close DJ-1 homologs (54). It is possible that these proteins share an evolutionarily conserved function in
detoxifying an electrophilic cyclic 1,3-phosphoglycerate intermediate that is spontaneously
formed by intramolecular cyclization of 1,3-bisphosphoglycerate (54). This metabolite
should be formed in all organisms that use glycolysis and thus provides a possible explanation for why the minimal Mycoplasma JCVI-Syn3A would need to preserve this pathway.
Conclusion. Metabolite damage arising from side reactions of enzymes and spontaneous chemistry has often been ignored or seen as a minor metabolic inconvenience—even
a trivial sideshow—that does not warrant investment in enzymes to prevent or repair it
(6). Biochemical, genetic, and engineering evidence accumulating over the past decade
has started to change this view (6, 8, 13, 15, 55, 56). The biochemical and genetic results
presented here constitute persuasive additional evidence by demonstrating that stripping
a genome down to its barest essentials leaves metabolite damage control systems in
place. Furthermore, our metabolomic and cheminformatic results point to the existence of
a network of metabolite damage and damage control reactions that extends far beyond
the corners of it characterized so far. In sum, there can be little room left to doubt that
damage itself and the systems that counter it are mainstream metabolic processes.
MATERIALS AND METHODS
Bioinformatics. The BLAST tools (57) and CDD resources at NCBI (http://www.ncbi.nlm.nih.gov/) (58)
were routinely used. Sequences were aligned using Clustal Omega (59) or Multalin (60). Phylogenetic
distribution was analyzed in the SEED database (61). Results are available in the “YqeK” subsystem on
the PubSEED server (http://pubseed.theseed.org//SubsysEditor.cgi?page=ShowSpreadsheet&subsystem=
NadD-YqeK_fusion_display). Physical clustering was analyzed with the SEED subsystem coloring tool or
the SeedViewer Compare Regions tool (61), and the clustering ﬁgure was generated with Gene Graphics
(62). Phylogenetic trees were constructed with MEGA6 (63). Student’s t test calculations were performed
using the VassarStats web tools (http://vassarstats.net).
Prediction of novel potential chemistry using PickAxe. Expanded chemistry was generated using
the PickAxe app in KBase, as shown in the narrative at https://narrative.kbase.us/narrative/29280. This
app uses the open-source RDKit package to apply sets of SMARTS-based chemical reaction rules, derived
from previously published chemical damage (8) and enzyme promiscuity (35) studies, to an input set of
compounds to produce all possible reactions and products that might arise from that chemistry. This
analysis can be run iteratively through repeated application of the reaction rules to all new products
that arise from previous generations. We applied the PickAxe approach for six iterations, retaining all
compounds that matched the JCVI-Syn3A model, the ModelSEED database (34), or an observed
metabolite.
Metabo-FBA to predict minimal reactions to reach observed metabolites. In metabo-ﬂux balance
analysis (metabo-FBA), constraints are added to the standard FBA formulation to force ﬂux through one or
more reactions involving an observed metabolite. In this formulation, a variable is added for each observed
peak (pi) and a variable is added for each metabolite that has been mapped to the peak (because peaks lack
stereochemistry, they may be mapped to multiple possible stereoisomers). Next, a constraint is added stating
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that a peak cannot be active unless one or more of its associated metabolites is active (where l i,j is a mapping variable equal to 1 if metabolite j is mapped to peak i and zero otherwise):

X

Compounds

pi #

l i;j mj

j

A constraint is also added stating that no metabolite can be active unless at least one reaction in
which the metabolite is involved is carrying ﬂux (where gj,k is a mapping variable equal to 1 if metabolite
j is involved in reaction k and zero otherwise):

X

Reactions

mj #

100 gj;k vk

k

To maximize active metabolites, the objective of the problem is then set to maximize the sum of all pi.
While pi and mj can be speciﬁed as binary variables, it works equally well and is less computationally expensive to use continuous variables bounded between 0 and 0.1. To avoid the trivial solution of activating
metabolites by pushing ﬂux through both directions of reversible reactions or around mass-balanced ﬂux
loops, it is essential to also employ thermodynamics constraints in some form in this formulation (64).
Media, strains, and genetic manipulations. All strains, plasmids, and oligonucleotides used in this
study are listed in Table A4 and Table A5 at ﬁgshare (https://doi.org/10.6084/m9.ﬁgshare.20020574).
Bacterial growth media were solidiﬁed with 15 g/L agar (BD Diagnostics Systems) for the preparation of
plates. E. coli was routinely grown on LB medium (BD Diagnostics Systems) at 37°C unless otherwise
stated. Transformations were performed following standard procedures (62). Isopropyl- b -D-thiogalactopyranoside (IPTG; 100 m M), ampicillin (Amp; 100 m g/mL), kanamycin (Km; 50 m g/mL), L-arabinose (Ara;
0.02 to 0.2%), chloramphenicol (Cm; 25 m g/mL), and rifampicin (Rif; 25 m g/mL) were used when appropriate. Bacterial M9 minimal medium (65), 0.4% (wt/vol) glucose, was used either with NH4Cl (20 mM) or
with glycine (50 mM) as the nitrogen source. P1 transduction was performed following the classical methods
(66). The Kanr marker was eliminated from the BW2113 DyajL::Kanr strain by the procedure described by
Cherepanov and Wackernagel (67). Transductants from BW2113 DhchA::Kanr to BW2113DyajL were checked
by PCR for transduction of the DhchA::Kanr allele into the recipient strains using primer pairs DH492/493
(ext)-DH494/495 (int) and DH480/481 (ext)-DH482/483 (int), respectively. Plasmid constructions for expression of JCVI-Syn3A genes in E. coli are described in the Supplemental Methods at ﬁgshare (https://doi.org/10
.6084/m9.ﬁgshare.20020574).
JCVI-Syn3A is a near-minimal bacterial cell ﬁrst reported by Breuer et al. (3) that contains a subset of
the genes in Mycoplasma mycoides subsp. capri strain GM12. Mycoplasmas were grown in SP4 broth (68)
that contains 17% KnockOut serum replacement instead of 17% fetal bovine serum and is referred to as
SP4-KO as described in the Supplemental Methods at ﬁgshare (https://doi.org/10.6084/m9.ﬁgshare
.20020574). Construction of gene knockout mutants in JCVI-Syn3A was a multistep process, and two different protocols were used. These protocols are described in detail in the Supplemental data S2 ﬁle at
ﬁgshare (https://doi.org/10.6084/m9.ﬁgshare.20020574).
Mutation frequency assays for E. coli derivatives. Overnight cultures in LB with added antibiotics
and arabinose (0.02%) were diluted 100-fold under the same conditions and grown for another 24 h
before dilutions were plated on LB and LB-rifampicin (25 m g/mL) to calculate a mutation ratio (number
of colonies on Rif  dilution factor)/(number of colonies on LB  dilution factor).
Protein expression and puriﬁcation and enzyme assays. All characterized JCVI-Syn3A-encoded proteins were expressed as His-tagged variants in E. coli and puriﬁed using Ni21-NTA (nitrilotriacetic acid) columns as described in the Supplemental Methods at ﬁgshare (https://doi.org/10.6084/m9.ﬁgshare.20020574).
In vitro activity assays for CoA disulﬁde reductase, for phosphatase with a range of substrates, NadD, glyoxalase, and deglycase are described in detail in the Supplemental Methods at the ﬁgshare URL above.
Data availability. The appendix and supplemental data have been deposited in the ﬁgshare data
depository with the DOI https://doi.org/10.6084/m9.ﬁgshare.20020574.
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